Second of two phase I drug-interaction trials of flibanserin in volunteers

Trial Profile

Second of two phase I drug-interaction trials of flibanserin in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Feb 2015

At a glance

  • Drugs Flibanserin (Primary)
  • Indications Female sexual dysfunction
  • Focus Adverse reactions; Registrational
  • Most Recent Events

    • 17 Feb 2015 The NDA for flibanserin for hypoactive sexual desire disorder in premenopausal women has been resubmitted to the US FDA, according to a Sprout Pharmaceuticals media release.
    • 14 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top